POINT Biopharma Global Inc.
NASDAQ:PNT
12.5 (USD) • At close December 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Assets: | ||||
| Current Assets: | ||||
| Cash & Cash Equivalents
| 286.428 | 238.816 | 10.547 | 0 |
| Short Term Investments
| 238.783 | 0 | 135,706.395 | 0 |
| Cash and Short Term Investments
| 525.212 | 238.816 | 10.547 | 0 |
| Net Receivables
| 0.06 | 0.073 | 0.059 | 0 |
| Inventory
| 5.335 | 4.852 | 1.764 | 0 |
| Other Current Assets
| 0.215 | 0.105 | 0.028 | 0.001 |
| Total Current Assets
| 530.823 | 243.847 | 12.397 | 0.001 |
| Non-Current Assets: | ||||
| Property, Plant & Equipment, Net
| 31.381 | 19.412 | 9.797 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 |
| Long Term Investments
| 16.119 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| -47.5 | -19.412 | -9.797 | 0 |
| Total Non-Current Assets
| 47.5 | 19.412 | 9.797 | 0 |
| Total Assets
| 578.323 | 263.259 | 22.194 | 0.001 |
| Liabilities & Equity: | ||||
| Current Liabilities: | ||||
| Account Payables
| 7.677 | 1.738 | 3.596 | 0 |
| Short Term Debt
| 0 | 0 | 0 | 0 |
| Tax Payables
| 29.699 | 0.251 | 0.088 | 0 |
| Deferred Revenue
| 23.242 | 0 | 0 | 0 |
| Other Current Liabilities
| 48.82 | 6.241 | 1.568 | 0.01 |
| Total Current Liabilities
| 79.738 | 7.98 | 5.164 | 0.01 |
| Non-Current Liabilities: | ||||
| Long Term Debt
| 0 | 0 | 3.551 | 0 |
| Deferred Revenue Non-Current
| 10.178 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0.066 | 0 | 0 |
| Other Non-Current Liabilities
| 1.452 | 0 | -3.551 | 0 |
| Total Non-Current Liabilities
| 11.631 | 0.066 | 3.551 | 0 |
| Total Liabilities
| 91.369 | 8.046 | 8.714 | 0.01 |
| Equity: | ||||
| Preferred Stock
| 0 | 0 | 0 | 0 |
| Common Stock
| 0.011 | 0.009 | 0.005 | 0 |
| Retained Earnings
| 39.009 | -59.285 | -13.382 | -0.009 |
| Accumulated Other Comprehensive Income/Loss
| -0.457 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 448.392 | 314.489 | 26.857 | 0 |
| Total Shareholders Equity
| 486.954 | 255.213 | 13.48 | -0.009 |
| Total Equity
| 486.954 | 255.213 | 13.48 | -0.009 |
| Total Liabilities & Shareholders Equity
| 578.323 | 263.259 | 22.194 | 0 |